Published in J Neurol on April 09, 2015
Ocular motor signatures of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol (2015) 0.77
Impairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis. Front Neurol (2016) 0.75
Capturing saccades in multiple sclerosis with a digitized test of rapid number naming. J Neurol (2017) 0.75
Working memory: theories, models, and controversies. Annu Rev Psychol (2011) 4.68
Topographic maps of visual spatial attention in human parietal cortex. J Neurophysiol (2005) 2.63
Load-dependent roles of frontal brain regions in the maintenance of working memory. Neuroimage (1999) 2.19
Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol (2003) 1.79
Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol (2000) 1.69
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol (2001) 1.64
Cognitive control of saccadic eye movements. Brain Cogn (2008) 1.38
Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry (2003) 1.28
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler (2007) 1.19
Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci (2007) 1.15
Cortical pathology and cognitive impairment in multiple sclerosis. Expert Rev Neurother (2011) 1.10
Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. Neuroimage (2007) 1.04
Is the n-back task a valid neuropsychological measure for assessing working memory? Arch Clin Neuropsychol (2009) 1.02
Functional magnetic resonance imaging and cognition at the very early stage of MS. J Neurol Sci (2006) 1.01
Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp (2005) 0.99
The bouncer in the brain. Nat Neurosci (2008) 0.97
Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis. Neuroimage (2004) 0.96
Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol (2002) 0.96
The effect of cognitive load on saccadic eye movements. Acta Psychol (Amst) (2000) 0.92
Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry (2011) 0.92
Antisaccade performance in patients with multiple sclerosis. Cortex (2009) 0.90
Altered functional connectivity related to white matter changes inside the working memory network at the very early stage of MS. J Cereb Blood Flow Metab (2005) 0.90
Multiple sclerosis: Cognition and saccadic eye movements. J Neurol Sci (2008) 0.90
Control of visually guided saccades in multiple sclerosis: Disruption to higher-order processes. Neuropsychologia (2009) 0.89
Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen (2002) 0.88
Longitudinal assessment of antisaccades in patients with multiple sclerosis. PLoS One (2012) 0.87
A neural model of sequential movement planning and control of eye movements: Item-Order-Rank working memory and saccade selection by the supplementary eye fields. Neural Netw (2011) 0.82
PASAT in detecting cognitive impairment in relapsing-remitting MS. Appl Neuropsychol (2007) 0.81
Cognition and eye movements: assessment of cerebral dysfunction. J Neuroophthalmol (2012) 0.80
Novel n-back spatial working memory task using eye movement response. Behav Res Methods (2011) 0.77
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain (2011) 3.48
Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol (2006) 3.38
Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects. Am J Orthod Dentofacial Orthop (2003) 3.35
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol (2010) 2.96
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol (2012) 2.79
Factors that influence adherence with disease-modifying therapy in MS. J Neurol (2009) 2.67
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol (2006) 2.62
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43
The neuro-ophthalmology of multiple sclerosis. Lancet Neurol (2005) 2.39
Early treatment for Class II Division 1 malocclusion with the Twin-block appliance: a multi-center, randomized, controlled trial. Am J Orthod Dentofacial Orthop (2009) 2.34
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol (2013) 2.22
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain (2011) 2.21
Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol (2008) 2.20
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology (2013) 2.06
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler (2011) 2.02
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol (2005) 2.02
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol (2008) 1.88
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol (2009) 1.85
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics (2011) 1.57
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology (2012) 1.51
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler (2013) 1.47
Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology (2013) 1.46
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain (2010) 1.45
Ischaemic stroke: the ocular motor system as a sensitive marker for motor and cognitive recovery. J Neurol Neurosurg Psychiatry (2012) 1.43
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol (2012) 1.36
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest (2002) 1.36
Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain (2008) 1.32
Current and emerging therapies in multiple sclerosis: a systematic review. Ther Adv Neurol Disord (2012) 1.31
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler (2010) 1.29
Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol (2008) 1.25
Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Arch Neurol (2009) 1.24
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol (2008) 1.20
Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology (2010) 1.20
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol (2011) 1.17
Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol (2005) 1.14
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol (2010) 1.13
Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol (2010) 1.11
Thermoregulation in multiple sclerosis. J Appl Physiol (1985) (2010) 1.10
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Arch Neurol (2007) 1.09
The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One (2011) 1.09
Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol (2011) 1.07
Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 2: Psychosocial effects. Am J Orthod Dentofacial Orthop (2003) 1.05
Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Ann N Y Acad Sci (2011) 1.02
Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat Rev Neurol (2010) 1.01
Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion. Arch Neurol (2006) 1.01
Biomarkers of exposure to combustion by-products in a human population in Shanxi, China. J Expo Sci Environ Epidemiol (2009) 1.00
Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin Immunol (2008) 0.98
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol (2009) 0.96
Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J Autoimmun (2011) 0.96
Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome. Neurosci Biobehav Rev (2013) 0.95
Effectiveness of treatment for Class II malocclusion with the Herbst or twin-block appliances: a randomized, controlled trial. Am J Orthod Dentofacial Orthop (2003) 0.95
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity. Autoimmunity (2012) 0.95
Direct and consensual murine pupillary reflex metrics: establishing normative values. Auton Neurosci (2009) 0.93
Transverse myelitis. Neurol Clin (2013) 0.92
Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome. Arch Neurol (2004) 0.92
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord (2010) 0.91
Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Arch Neurol (2008) 0.91
PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS One (2009) 0.90
Multiple sclerosis: Cognition and saccadic eye movements. J Neurol Sci (2008) 0.90
Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. J Neuroophthalmol (2012) 0.90
Antisaccade performance in patients with multiple sclerosis. Cortex (2009) 0.90
Control of visually guided saccades in multiple sclerosis: Disruption to higher-order processes. Neuropsychologia (2009) 0.89
No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis. Arch Neurol (2011) 0.89
Uhthoff's phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol (2013) 0.89
Greater disruption to control of voluntary saccades in autistic disorder than Asperger's disorder: evidence for greater cerebellar involvement in autism? Cerebellum (2011) 0.88
Inhibitory control and spatial working memory in Parkinson's disease. Mov Disord (2007) 0.88
A new measure of dysconjugacy in INO: the first-pass amplitude. J Neurol Sci (2003) 0.88
No sequence dependent modulation of the Simon effect in Parkinson's disease. Brain Res Cogn Brain Res (2005) 0.87
Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol (2013) 0.87
WEBINO and the return of the King's Speech. J Neurol Sci (2011) 0.87
Longitudinal assessment of antisaccades in patients with multiple sclerosis. PLoS One (2012) 0.87
Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis. Invest Ophthalmol Vis Sci (2012) 0.86
A closer look at visually guided saccades in autism and Asperger's disorder. Front Integr Neurosci (2012) 0.86
Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. Am J Med Genet B Neuropsychiatr Genet (2013) 0.86
Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis. Urology (2006) 0.85
Retinal damage and vision loss in African American multiple sclerosis patients. Ann Neurol (2015) 0.84
Pharmacological treatment of early multiple sclerosis. Drugs (2008) 0.84
Ocular motor fixation deficits in Friedreich ataxia. Cerebellum (2010) 0.84